FDA
-
-
-
-
-
-
-
Varian Reports Results for Fourth Quarter of Fiscal Year 2020
-
-
-
-
-
-
-
Varian Announces Appointment of Chris Toth as President and Chief Operating Officer
-
-
-
-
-
-
-
Varian Medical Systems (VAR) Receives FDA 510(k) Clearance for Ethos Therapy
-
-
-
-
-
-
-
Varian Updates Investors on Proposed Reimbursement Changes
-
-
-
-
-
-
-
Varian Announces Definitive Agreement to Acquire Cancer Treatment Services International
-
-
-
-
-
-
-
Varian U.S. Tariff Exclusion Request Granted for Halcyon Radiotherapy System for Cancer Treatments
-
-
-
-
-
-
-
Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

